Mereo BioPharma Group PLC (MREO)
3.50
-0.25
(-6.67%)
USD |
NASDAQ |
Jun 25, 16:00
3.62
+0.12
(+3.43%)
After-Hours: 20:00
Mereo BioPharma Group Accounts Payable (Quarterly): 2.455M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.455M |
| June 30, 2023 | 2.410M |
| June 30, 2023 | 2.410M |
| December 31, 2022 | 3.492M |
| June 30, 2022 | 3.422M |
| June 30, 2022 | 3.422M |
| December 31, 2021 | 3.084M |
| June 30, 2021 | 3.027M |
| June 30, 2021 | 3.027M |
| December 31, 2020 | 4.313M |
| June 30, 2020 | 6.756M |
| June 30, 2020 | 6.756M |
| December 31, 2019 | 8.061M |
| Date | Value |
|---|---|
| June 30, 2019 | 8.565M |
| June 30, 2019 | 8.565M |
| December 31, 2018 | 5.574M |
| June 30, 2018 | 6.516M |
| June 30, 2018 | 6.516M |
| December 31, 2017 | 3.865M |
| June 30, 2017 | 15.52M |
| June 30, 2017 | 15.52M |
| December 31, 2016 | 1.228M |
| June 30, 2016 | 7.762M |
| June 30, 2016 | 7.762M |
| December 31, 2015 | 1.872M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.410M
Minimum
Jun 2023
8.565M
Maximum
Jun 2019
4.651M
Average
3.422M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 6.587M |
| Biodexa Pharmaceuticals Plc | 0.40M |
| NuCana PLC | 7.277M |
| Verona Pharma PLC | 4.651M |
| Autolus Therapeutics PLC | 1.399M |